Cargando…

DNA Prime/Adenovirus Boost Malaria Vaccine Encoding P. falciparum CSP and AMA1 Induces Sterile Protection Associated with Cell-Mediated Immunity

BACKGROUND: Gene-based vaccination using prime/boost regimens protects animals and humans against malaria, inducing cell-mediated responses that in animal models target liver stage malaria parasites. We tested a DNA prime/adenovirus boost malaria vaccine in a Phase 1 clinical trial with controlled h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chuang, Ilin, Sedegah, Martha, Cicatelli, Susan, Spring, Michele, Polhemus, Mark, Tamminga, Cindy, Patterson, Noelle, Guerrero, Melanie, Bennett, Jason W., McGrath, Shannon, Ganeshan, Harini, Belmonte, Maria, Farooq, Fouzia, Abot, Esteban, Banania, Jo Glenna, Huang, Jun, Newcomer, Rhonda, Rein, Lisa, Litilit, Dianne, Richie, Nancy O., Wood, Chloe, Murphy, Jittawadee, Sauerwein, Robert, Hermsen, Cornelus C., McCoy, Andrea J., Kamau, Edwin, Cummings, James, Komisar, Jack, Sutamihardja, Awalludin, Shi, Meng, Epstein, Judith E., Maiolatesi, Santina, Tosh, Donna, Limbach, Keith, Angov, Evelina, Bergmann-Leitner, Elke, Bruder, Joseph T., Doolan, Denise L., King, C. Richter, Carucci, Daniel, Dutta, Sheetij, Soisson, Lorraine, Diggs, Carter, Hollingdale, Michael R., Ockenhouse, Christian F., Richie, Thomas L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3573028/ https://www.ncbi.nlm.nih.gov/pubmed/23457473 http://dx.doi.org/10.1371/journal.pone.0055571

Ejemplares similares

Identification of minimal human MHC-restricted CD8+ T-cell epitopes within the Plasmodium falciparum circumsporozoite protein (CSP)
por: Sedegah, Martha, et al.
Publicado: (2013)

Adenovirus-5-Vectored P. falciparum Vaccine Expressing CSP and AMA1. Part B: Safety, Immunogenicity and Protective Efficacy of the CSP Component
por: Tamminga, Cindy, et al.
Publicado: (2011)

Human adenovirus 5-vectored Plasmodium falciparum NMRC-M3V-Ad-PfCA vaccine encoding CSP and AMA1 is safe, well-tolerated and immunogenic but does not protect against controlled human malaria infection
por: Tamminga, Cindy, et al.
Publicado: (2013)

Adenovirus 5-Vectored P. falciparum Vaccine Expressing CSP and AMA1. Part A: Safety and Immunogenicity in Seronegative Adults
por: Sedegah, Martha, et al.
Publicado: (2011)

Identification and localization of minimal MHC-restricted CD8+ T cell epitopes within the Plasmodium falciparum AMA1 protein
por: Sedegah, Martha, et al.
Publicado: (2010)

Sterile Immunity to Malaria after DNA Prime/Adenovirus Boost Immunization Is Associated with Effector Memory CD8+T Cells Targeting AMA1 Class I Epitopes
por: Sedegah, Martha, et al.
Publicado: (2014)

Ex vivo tetramer staining and cell surface phenotyping for early activation markers CD38 and HLA-DR to enumerate and characterize malaria antigen-specific CD8(+) T-cells induced in human volunteers immunized with a Plasmodium falciparum adenovirus-vectored malaria vaccine expressing AMA1
por: Schwenk, Robert, et al.
Publicado: (2013)

Measuring naturally acquired immune responses to candidate malaria vaccine antigens in Ghanaian adults
por: Dodoo, Daniel, et al.
Publicado: (2011)

IMRAS—Immunization with radiation-attenuated Plasmodium falciparum sporozoites by mosquito bite: Cellular immunity to sporozoites, CSP, AMA1, TRAP and CelTOS
por: Sedegah, Martha, et al.
Publicado: (2021)

IMRAS—A clinical trial of mosquito-bite immunization with live, radiation-attenuated P. falciparum sporozoites: Impact of immunization parameters on protective efficacy and generation of a repository of immunologic reagents
por: Hickey, Bradley, et al.
Publicado: (2020)

Controlled Human Malaria Infection (CHMI) differentially affects cell-mediated and antibody responses to CSP and AMA1 induced by adenovirus vaccines with and without DNA-priming
por: Sedegah, Martha, et al.
Publicado: (2015)

Induction of multi-antigen multi-stage immune responses against Plasmodium falciparum in rhesus monkeys, in the absence of antigen interference, with heterologous DNA prime/poxvirus boost immunization
por: Jiang, George, et al.
Publicado: (2007)

Vaccine Strain-Specificity of Protective HLA-Restricted Class 1 P. falciparum Epitopes
por: Sedegah, Martha, et al.
Publicado: (2016)

Correction: Vaccine Strain-Specificity of Protective HLA-Restricted Class 1 P. falciparum Epitopes
por: Sedegah, Martha, et al.
Publicado: (2016)

A three-antigen Plasmodium falciparum DNA prime—Adenovirus boost malaria vaccine regimen is superior to a two-antigen regimen and protects against controlled human malaria infection in healthy malaria-naïve adults
por: Sklar, Marvin J., et al.
Publicado: (2021)

Clinical trial in healthy malaria-naïve adults to evaluate the safety, tolerability, immunogenicity and efficacy of MuStDO5, a five-gene, sporozoite/hepatic stage Plasmodium falciparum DNA vaccine combined with escalating dose human GM-CSF DNA
por: Richie, Thomas L., et al.
Publicado: (2012)

Identification of two new protective pre-erythrocytic malaria vaccine antigen candidates
por: Limbach, Keith, et al.
Publicado: (2011)

Results from tandem Phase 1 studies evaluating the safety, reactogenicity and immunogenicity of the vaccine candidate antigen Plasmodium falciparum FVO merozoite surface protein-1 (MSP1(42)) administered intramuscularly with adjuvant system AS01
por: Otsyula, Nekoye, et al.
Publicado: (2013)

Measurement of ex vivo ELISpot interferon-gamma recall responses to Plasmodium falciparum AMA1 and CSP in Ghanaian adults with natural exposure to malaria
por: Ganeshan, Harini, et al.
Publicado: (2016)

Measuring naturally acquired ex vivo IFN-γ responses to Plasmodium falciparum cell-traversal protein for ookinetes and sporozoites (CelTOS) in Ghanaian adults
por: Anum, Dorothy, et al.
Publicado: (2015)

Mosquito bite immunization with radiation-attenuated Plasmodium falciparum sporozoites: safety, tolerability, protective efficacy and humoral immunogenicity
por: Hickey, Bradley W., et al.
Publicado: (2016)

Phase 1/2a Trial of Plasmodium vivax Malaria Vaccine Candidate VMP001/AS01(B) in Malaria-Naive Adults: Safety, Immunogenicity, and Efficacy
por: Bennett, Jason W., et al.
Publicado: (2016)

Sterile Protection against Plasmodium knowlesi in Rhesus Monkeys from a Malaria Vaccine: Comparison of Heterologous Prime Boost Strategies
por: Jiang, George, et al.
Publicado: (2009)

High Antibody Titer against Apical Membrane Antigen-1 Is Required to Protect against Malaria in the Aotus Model
por: Dutta, Sheetij, et al.
Publicado: (2009)

Immunization with Pre-Erythrocytic Antigen CelTOS from Plasmodium falciparum Elicits Cross-Species Protection against Heterologous Challenge with Plasmodium berghei
por: Bergmann-Leitner, Elke S, et al.
Publicado: (2010)

Discovery of Novel Plasmodium falciparum Pre-Erythrocytic Antigens for Vaccine Development
por: Aguiar, Joao C., et al.
Publicado: (2015)

Phenotypic characterization of Plasmodium berghei responsive CD8+ T cells after immunization with live sporozoites under chloroquine cover
por: Brando, Clara, et al.
Publicado: (2014)

New gorilla adenovirus vaccine vectors induce potent immune responses and protection in a mouse malaria model
por: Limbach, Keith, et al.
Publicado: (2017)

Anti-sporozoite antibodies as alternative markers for malaria transmission intensity estimation
por: Kusi, Kwadwo A, et al.
Publicado: (2014)

Seroprevalence of Antibodies against Plasmodium falciparum Sporozoite Antigens as Predictive Disease Transmission Markers in an Area of Ghana with Seasonal Malaria Transmission
por: Kusi, Kwadwo A., et al.
Publicado: (2016)

Comparative evaluation of published real-time PCR assays for the detection of malaria following MIQE guidelines
por: Alemayehu, Saba, et al.
Publicado: (2013)

Phase 1/2a Study of the Malaria Vaccine Candidate Apical Membrane Antigen-1 (AMA-1) Administered in Adjuvant System AS01B or AS02A
por: Spring, Michele D., et al.
Publicado: (2009)

Seasonal prevalence of malaria in West Sumba district, Indonesia
por: Syafruddin, Din, et al.
Publicado: (2009)

Blood Stage Malaria Vaccine Eliciting High Antigen-Specific Antibody Concentrations Confers No Protection to Young Children in Western Kenya
por: Ogutu, Bernhards R., et al.
Publicado: (2009)

Profiling the Targets of Protective CD8(+) T Cell Responses to Infection
por: Bruder, Joseph T., et al.
Publicado: (2017)

Strain-specific Plasmodium falciparum growth inhibition among Malian children immunized with a blood-stage malaria vaccine
por: Laurens, Matthew B., et al.
Publicado: (2017)

Measurement of parasitological data by quantitative real-time PCR from controlled human malaria infection trials at the Walter Reed Army Institute of Research
por: Kamau, Edwin, et al.
Publicado: (2014)

Surveillance for Malaria Elimination in Swaziland: A National Cross-Sectional Study Using Pooled PCR and Serology
por: Hsiang, Michelle S., et al.
Publicado: (2012)

Commentary on: Application of embryonic equivalents in male-to-female sex reassignment surgery
por: Gupta, Richie
Publicado: (2018)

Sex, not gender. A plea for accuracy
por: Richie, Cristina
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_e3vl80l8a8afe1v1e6mgu2aemm